Healthy adult
Conditions
Interventions
Ingestion of a single intake and 4 consecutive weeks of active test food
Ingestion of a single intake and 4 consecutive weeks of placebo food
Sponsors
TTC Co., Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) Female workers from 30 to 49 years old (2) Clerical workers (3) Subjects who are feeling fatigue because of work
Exclusion criteria
Exclusion criteria: (1) Subjects who routinely use food or medicine containing of functional substance (2) Subjects who performs an act for the improvement of the blood flow, the fatigue, stress, and the quality of the sleep (3) Subjects who use the warm cream (4) Night and day shift worker or manual laborer (5) Subjects who has a disease under treatment or are judged to that medical treatment are necessary by the doctor (6) Subjects who has under treatment or a history of sleep apnea syndrome or is strongly suspected of sleep apnea syndrome (7) Subjects who has had a diagnosis of chronic fatigue syndrome (8) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) and disease to affect the adrenal cortical hormone secretion (9) Smokers (10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire and other questionnair (11) Subjects having possibilities for emerging allergy related to the study (12) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (13) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (14) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating (15) Subjects who are judged as unsuitable for the study by the investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood flow | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin surface temperature, POMS2, skin questionnaire | — |
Countries
Japan
Contacts
Public ContactTakashi Nakagawa
TTC Co., Ltd. Clinical Research Planning Department
Outcome results
None listed